Willis v. Roche Biomedical Laboratories, Inc.Willis v. Roche Biomedical Laboratories, Inc.
- Reporters:
- , , , ,
- Before:
- King, Jolly, Robert M. Parker
Jeffrey A. Lehmann, Houston, TX, for appellant.
D. Faye Caldwell, Jack E. Urquhart, Holtzman & Urquhart, Houston, TX, for Roche Biomedical.
Before KING, JOLLY and PARKER1, Circuit Judges.
ROBERT M. PARKER, Circuit Judge:
The original panel opinion in this cause, Willis v. Roche Biomedical Laboratories, Inc., 21 F.3d 1368 (5th Cir.1994), is withdrawn and this opinion is substituted in its stead.
Robert E. Willis (“Willis“) filed this action in Texas state court on July 31, 1991, asserting negligence and defamation claims arising out of a test of Willis‘s urine that resulted in a false positive for methamphetamines. Willis brought action against Roche Biomedical
On August 22, 1991, the Du Pont defendants, joined by Roche, removed the action to federal court on the ground that Willis‘s claim arose under the Labor Management Relations Act (“LMRA“),
On June 29, 1992, the district court granted Roche‘s motion for summary judgment and this appeal followed.
I. FACTS
The district court found that the following facts were established by the summary judgment evidence. Neither party disputes that this portion of the district court‘s opinion is correct.
Plaintiff-Appellant Willis has been employed by Du Pont at its LaPorte, Texas chemical plant since March 26, 1979 as a utility helper. At all times relevant to this lawsuit, his employment was governed by a collective bargaining agreement, (which included a substance abuse policy covering La Port plant employees. In July 1990, Du Pont, in alliance with the Union, instituted a random drug testing policy.
Du Pont contracted with Roche to conduct the screening and testing of urine samples provided by Du Pont in accordance with strict protocol procedures in the contract.
On August 2, 1990, Du Pont ordered that Willis participate in a random drug test, in accordance with its substance abuse policy. The test was performed by Roche and a report was issued to Du Pont, pursuant to a consent form signed by Willis. The report indicated that Willis had tested positive for methamphetamine use. Willis remained employed at Du Pont and continued to receive his regular salary after Du Pont received Roche‘s report. Willis was placed on restricted work duty and was sent to a physician. Willis was also required to attend counseling sessions and to submit to follow up testing.
On November 2, 1990, Roche informed Du Pont that Willis‘s drug test had registered a “false positive.” The false positive was the result of the test confusing the presence of over the counter cold medication with the presence of illegal methamphetamine in Willis‘s urine. Upon learning of the mistake, Du Pont compensated Willis for lost time and for medical expenses.
Willis brought suit for negligence, gross negligence, libel and slander, contending that his damages included various aspects of mental suffering and the loss of his good name and reputation. He also claimed monetary damages, but acknowledged that Du Pont had made monetary amends with regard to the payment of these sums in the form of repayment for lost work time and reimbursement for medical expenses.
II. GOVERNING LAW
In its order denying Willis‘s motion to remand the case to state court, the district court found that Willis‘s state law claims were preempted by
We hold that Willis‘s claims against Roche are not preempted by the LMRA, because they do not require an interpretation of the collective bargaining agreement for resolution. Rather, the district court had pendant jurisdiction over these state claims, and it appropriately applied Texas law.
III. STANDARD OF REVIEW
Willis challenges the district court‘s interpretation of Texas law and its determination that no genuine issue of material fact existed in the summary judgment record. We must review de novo the district court‘s determination of state law. Salve Regina College v. Russell, 499 U.S. 225, 239, 111 S.Ct. 1217, 1225, 113 L.Ed.2d 190 (1991) (“The obligation of responsible appellate review and the principle of a cooperative judicial federalism underlying Erie [R. Co. v. Tompkins, 304 U.S. 64, 58 S.Ct. 817, 82 L.Ed. 1188 (1938)] require that courts of appeals review the state-law determination of district courts de novo.“)
The standard of review at the appellate level of a district court‘s grant of summary judgment requires the same analysis as employed by the trial court.
This standard provides that the mere existence of some factual dispute will not defeat a motion for summary judgment; Rule 56 requires that the fact dispute be genuine and material. First, the substantive law will identify which facts are material. Only disputes over facts that might affect the outcome of the suit under the governing law will preclude summary judgment. Id. 477 U.S. at 248, 106 S.Ct. at 2510. Second, a dispute about a material fact is genuine if the evidence is such that a reasonable jury could return a verdict for the nonmoving party. Id.
IV. ANALYSIS
We now turn to the question of whether the district court erred in granting Roche‘s motion for summary judgment in this particular case.
A. WILLIS‘S NEGLIGENCE CLAIM
To recover under a negligence cause of action, Willis must establish that Roche owed a legal duty to him, and then, that Roche breached the duty and that Willis suffered damages proximately caused by the breach. See, e.g., Otis Engineering Corp. v. Clark, 668 S.W.2d 307, 312 (Tex.1983). The district court held that Roche owed no legal duty to Willis under Texas law to use reasonable care in its administration of the drug testing of Willis‘s urine sample. The district court found that Texas law was not sufficiently developed on the issue of a laboratory‘s liability for negligent drug testing for a federal court to make an “Erie prediction“, and thus the court was forced to rely on the law of negligence as it applies to physicians employed as independent contractors. With the benefit of a recent pronouncement from the Supreme Court of Texas, we now make the necessary Erie prediction. SmithKline Beecham Corp. v. Doe, 903 S.W.2d 347 (Tex.1995).
Doe sued, among others, the laboratory which conducted the testing, claiming that the laboratory owed her a duty to warn that poppy seeds could cause a positive test result. Reversing a court of appeals decision, the Supreme Court of Texas held that this duty did not exist. SmithKline, 903 S.W.2d at 348. The court recognized that SmithKline Beecham was an independent laboratory hired by the employer to conduct drug screening tests. The court did not consider the duties SmithKline Beecham owed the employer or the duties the employer may have owed Doe. Rather, the court focussed “exclusively on the relationship between the laboratory and the person tested.” SmithKline, 903 S.W.2d at 351.
The Texas high court noted that some jurisdictions had held that a laboratory owes a duty to persons tested to perform its services with reasonable care. Although distinguishing those decisions from the failure to warn claims before it, the court pointed out that whether an independent laboratory owes a duty of reasonable care is a question on which “[n]o court of last resort has spoken.” SmithKline, 903 S.W.2d at 352. In addition, the court seemed to question the soundness of the decisions finding such a duty.2 Reviewing decisions in a related context, the Texas court also noted that “the only court of last resort in any American jurisdiction to clearly consider the issue has held that no tort duty to use reasonable care should be imposed on polygraph test operators.” SmithKline, 903 S.W.2d at 352 (citing Hall v. United Parcel Serv. of Am., 76 N.Y.2d 27, 556 N.Y.S.2d 21, 24-26, 555 N.E.2d 273, 276-78 (1990)).
Although the Supreme Court of Texas emphasized in SmithKline that it was not considering whether a drug testing laboratory has a duty to use reasonable care in performing tests and reporting results, we must consider what the court did say in determining what Texas law is. Recognizing the risks inherent in making an Erie “guess“, we find that under current Texas law, Roche owed Willis no duty of reasonable care in testing his urine for drugs.
B. WILLIS‘S DEFAMATION CLAIM
Second, Willis seeks damages arising from the publication of the false positive test results. Roche responds that Willis signed a consent form granting permission to release the results of such tests to the company. The pertinent consent form language reads, “I furthermore give (outside laboratory) my permission to release the results of such tests to the company.” (Record Vol. 1, p. 252). However, we need not address whether this release was effective because we agree with the district court‘s reasoning that in any event Roche‘s communication was qualifiedly privileged.
The district court assumed arguendo, without holding, that there was no valid consent and that the report was defamatory, but found that Roche‘s publication was qualifiedly privileged, citing Boze v. Branstetter, 912 F.2d 801, 806 (5th Cir.1990). The opinion reasons:
The privilege advances “the need for free communication of information to protect business and personal interests.” Gaines v. CUNA Mut. Ins. Soc‘y, 681 F.2d 982, 986 (5th Cir.1982). In order for the moving party to prevail on a summary judgment asserting this privilege, however, an absence of malice must be shown. Houston v. Grocers Supply Co., Inc., 625 S.W.2d [798] at 801 [(Tex.App.—Houston [14th Dist.] 1981)].
Willis does not directly challenge this holding, but it is not entirely clear that he has abandoned his defamation claim. We nonetheless agree with the reasoning and conclusion reached by the district court and hold that it was correct in granting Roche summary judgment on the defamation claim.
V. CONCLUSION
The district court‘s order granting summary judgment in favor of Roche is AFFIRMED.
ROBERT M. PARKER
CIRCUIT JUDGE